Overview
Also known as:
FDA & Trial Timeline
2 eventsNational and Kapodistrian University of Athens
treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableEnspryng
treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive
Clinical Trials
View all trials with filters →No actively recruiting trials found for Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesTravel Grants
No travel grants are currently matched to Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies.
Community
No community posts yet. Be the first to share your experience with Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies.
Start the conversation →Latest news about Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies
No recent news articles for Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies
Which specialists treat Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies?
2 specialists and care centers treating Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies?
1 patient support program are currently tracked on UniteRare for Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies. See the treatments and support programs sections for copay assistance, eligibility, and contact details.